Industry Pulse

Discover how peptide synthesis enables precise construction of therapeutic and functional peptides. Learn about SPPS, continuous-flow methods, automated platforms, and recent innovations transforming peptide research and drug development.

CPHI South East Asia 2026 is not just another trade show—it’s a strategic meeting point for the ASEAN pharmaceutical ecosystem. Whether you’re a materials supplier, API manufacturer, CDMO, or service provider, attending gives you a front-row view of the region’s dynamic growth and connection to the global supply chain.

Explore cutting-edge innovations in peptide synthesizers, including continuous-flow, microwave-assisted, and microfluidic systems, enhancing speed, efficiency, and peptide synthesis quality.

A landmark study published in Nature Communications by Jacopo Zero, Tristan J. Tyler, and Professor Leroy Cronin (2025) describes a fully automated and programmable peptide synthesis platform that fuses Solid-Phase Peptide Synthesis (SPPS) with a robotic, chemical-processing unit known as the Chemputer.

CPHI South East Asia 2026 is not just another trade show—it’s a strategic meeting point for the ASEAN pharmaceutical ecosystem. Whether you’re a materials supplier, API manufacturer, CDMO, or service provider, attending gives you a front-row view of the region’s dynamic growth and connection to the global supply chain.

Discover what Solid-Phase Peptide Synthesis (SPPS) is, how it works, and why it’s essential in modern peptide research and drug development. Learn the advantages, challenges, and future trends of automated peptide synthesis.

Join Pharmapack Europe 2026 on January 21–22 at Paris Expo, Porte de Versailles. Explore innovations in pharmaceutical packaging, drug delivery systems, medical devices, and sustainable solutions with 400+ exhibitors and 6,000+ attendees.

Explore CPhI Europe 2025, the leading pharmaceutical exhibition, highlighting trends in peptide research and peptide synthesizer technologies.CPhI Europe 2025 is a premier event for the pharmaceutical industry, highlighting the latest advancements in peptides and related technologies. Researchers and industry professionals can explore peptide synthesizer innovations, network with global peers, and gain actionable insights into the evolving peptide landscape.

With the peptide synthesis market projected to grow at 7–12% annually worldwide (Grand View Research; MarketsandMarkets; Precedence Research), laboratories and enterprises must invest in future-proof, flexible, and compliant equipment.

Dilunbio stands out with:

• A full-spectrum product portfolio (research to industrial).

• Asynchronous multi-channel synthesis for unmatched flexibility.

• High-throughput capabilities (up to 106 independent reactors).

• 21 CFR Part 11 compliance with intelligent remote control.

• Proven domestic adoption and international exports.

For researchers, pharma innovators, and manufacturing enterprises seeking comprehensive, efficient, and regulatory-compliant peptide synthesis solutions, Dilunbio is a strategic partner you can trust.